Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

41 trials

NCT07778667
Recruiting
A Study to Learn How Well Lucerastat Works and How Safe it is in Untreated Adult Male Participants With Fabry Disease
Phase 3 · Canada, Germany, France, United Kingdom, United States · 16 sites
Registry update: 3 Nov 2026
NCT07109375
Recruiting
Observational Study on Long-term Use of Pegunigalsidase Alfa in Fabry Patients in a Real-world Setting
Not applicable · Italy · 7 sites
Registry update: 8 Jul 2026
NCT07575347
Recruiting
Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)
Not applicable · Romania · 1 site
Registry update: 26 Jun 2026
2025-521408-24-00
Recruiting
Low dose corticosteroids adjacent to enzyme replacement therapy or chaperon therapy in patients with cardiac manifestation of Fabry disease
Phase 3 · Poland · 2 sites
Registry update: 4 Nov 2026
NCT06906367
Recruiting
A Study of Patients With Fabry Disease (US Specific)
Not applicable · United States · 8 sites
Registry update: 28 Oct 2026
NCT06904261
Recruiting
A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
Phase 3 · Belgium, Germany, Spain, United Kingdom, Japan, United States · 12 sites
Registry update: 22 Oct 2026
NCT07235709
Recruiting
Effect of Agalsidase Alfa on Cardiac Inflammation in Patients With Fabry Disease: A [18F]-FDG PET-CMR Study
Not applicable · South Korea · 1 site
Registry update: 1 Dec 2025
NCT07187440
Recruiting
A Study of Agalsidase Alfa Enyzme Replacement Therapy in Chinese Children and Adults With Fabry Disease
Not applicable · China · 18 sites
Registry update: 2 Jan 2026
NCT07495410
Recruiting
Anderson-Fabry Disease Fitness Improvement Training
Not applicable · Czechia · 1 site
Registry update: 21 Sept 2026
NCT06328608
Recruiting
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
Phase 2/3 · Austria, Spain, France, United Kingdom, Norway, United States · 12 sites
Registry update: 10 Aug 2026
NCT07382128
Recruiting
Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes
Not applicable · Italy · 1 site
Registry update: 2 Feb 2026
NCT06941025
Recruiting
Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
Not applicable · Germany, Spain, United Kingdom, Italy, United States · 5 sites
Registry update: 19 Mar 2026
NCT06858397
Recruiting
A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
Phase 1/2 · Argentina, South Korea, United States · 10 sites
Registry update: 4 Nov 2025
NCT06776419
Recruiting
the Role of cArdiac Inflammation, endoThelial Dysfunction, and FIbrosis in fabrY Disease
Not applicable · Denmark · 1 site
Registry update: 8 Apr 2025
NCT04252066
Recruiting
A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
Not applicable · United States · 1 site
Registry update: 28 Oct 2026
NCT06512571
Recruiting
CVI Alterations in FD: a Prospective, Multicenter, Observational Cohort Study
Not applicable · China · 1 site
Registry update: 26 Mar 2025
NCT06884358
Recruiting
Functional Capacity in Anderson-Fabry Disease Patients
Not applicable · Italy · 5 sites
Registry update: 2 Jul 2026
NCT06663358
Recruiting
A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients
Not applicable · United Kingdom, Slovenia, United States · 10 sites
Registry update: 14 Nov 2025
NCT06539624
Recruiting
Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease
Not applicable · China · 2 sites
Registry update: 27 Feb 2026
NCT07277361
Recruiting
Study of the Quality of Life of Patients With Fabry Disease Aged 65 and Over With and Without Specific Treatment
Not applicable · France · 1 site
Registry update: 11 Dec 2025

Ordered by registry start date. Freshness and sponsorship never change the order.